WinSanTor Inc. is a clinical-stage biotechnology company focused on the discovery and development of treatments for peripheral neuropathies, including diabetic peripheral neuropathy, chemo-induced peripheral neuropathy, HIV-induced and others. WinSanTor was founded by scientists and industry experts who share the vision that recent scientific insights into the biological processes underlying degenerative diseases offer an unprecedented opportunity to discover and develop effective medicines. WinSanTor is rigorously pursuing a science-driven approach to translational medicine and clinical development.
View Top Employees from WinSanTorWebsite | http://www.winsantor.com |
Revenue | $1 million |
Employees | 20 (20 on RocketReach) |
Founded | 2011 |
Address | 6150 Lusk Blvd B201, Suite B201, San Diego, California 92121, US |
Phone | (858) 208-0546 |
Technologies |
JavaScript,
HTML,
PHP
+22 more
(view full list)
|
Industry | Biotechnology Research, Drug Stores & Pharmacies, Biotechnology, Retail, Science and Engineering |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular WinSanTor employee's phone or email?
The WinSanTor annual revenue was $1 million in 2024.
Andrew Albertson is the CFO of WinSanTor.
20 people are employed at WinSanTor.
WinSanTor is based in San Diego, California.
The NAICS codes for WinSanTor are [325, 3254, 32541, 32].
The SIC codes for WinSanTor are [283, 28].